Aligned Genetics Inc (238120) - Total Liabilities

Latest as of September 2025: ₩9.61 Billion KRW ≈ $6.51 Million USD

Based on the latest financial reports, Aligned Genetics Inc (238120) has total liabilities worth ₩9.61 Billion KRW (≈ $6.51 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Aligned Genetics Inc cash flow conversion to assess how effectively this company generates cash.

Aligned Genetics Inc - Total Liabilities Trend (2015–2024)

This chart illustrates how Aligned Genetics Inc's total liabilities have evolved over time, based on quarterly financial data. Check Aligned Genetics Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Aligned Genetics Inc Competitors by Total Liabilities

The table below lists competitors of Aligned Genetics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Wikana SA WAR:WIK	Poland	zł105.99 Million
Battalion Oil Corp NYSE MKT:BATL	USA	$511.94 Million
Haoxi Health Technology Limited Class A Ordinary Shares NASDAQ:HAO	USA	$4.22 Million
Seoul Food KO:004410	Korea	₩46.52 Billion
Kedawung Setia Industrial Tbk JK:KDSI	Indonesia	Rp490.81 Billion
Routon Electronic Co Ltd SHG:600355	China	CN¥147.15 Million
Imago Mulia Persada Tbk PT JK:LFLO	Indonesia	Rp89.24 Billion
WebCash Corporation KQ:053580	Korea	₩22.36 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down Aligned Genetics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 238120 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	10.05	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.27	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.21	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Aligned Genetics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Aligned Genetics Inc (2015–2024)

The table below shows the annual total liabilities of Aligned Genetics Inc from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩8.78 Billion ≈ $5.95 Million	-8.73%
2023-12-31	₩9.62 Billion ≈ $6.52 Million	+19.48%
2022-12-31	₩8.05 Billion ≈ $5.46 Million	+7.68%
2021-12-31	₩7.48 Billion ≈ $5.07 Million	+86.12%
2020-12-31	₩4.02 Billion ≈ $2.72 Million	+9.99%
2019-12-31	₩3.65 Billion ≈ $2.48 Million	+72.88%
2018-12-31	₩2.11 Billion ≈ $1.43 Million	+26.75%
2017-12-31	₩1.67 Billion ≈ $1.13 Million	-0.67%
2016-12-31	₩1.68 Billion ≈ $1.14 Million	+110.80%
2015-12-31	₩796.04 Million ≈ $539.46K	--

About Aligned Genetics Inc

KQ:238120 Korea Medical Devices

Market Cap

$41.78 Million

₩61.65 Billion KRW

Market Cap Rank

#22538 Global

#1528 in Korea

Share Price

₩4385.00

Change (1 day)

+1.62%

52-Week Range

₩3080.00 - ₩6050.00

All Time High

₩7875.00